GUEST COLUMNISTS

  • Think A Quality Culture Doesn’t Affect Your Bottom Line? Think Again
    Think A Quality Culture Doesn’t Affect Your Bottom Line? Think Again

    Maintaining quality is everyone’s job and a team effort. And when it is overlooked, bad things happen. News of a pharmaceutical company receiving an FDA Complete Response Letter and Form 483 — citing data manipulation and breaches — drove this point home recently. Based on the FDA observations made in this case, there is clear evidence that components of a voluntary quality assurance (VQA) culture were missing.

  • 5 Barriers To Blockchain Adoption In The Rx Supply Chain — And How To Overcome Them
    5 Barriers To Blockchain Adoption In The Rx Supply Chain — And How To Overcome Them

    Blockchain has already started to find fit-for-purpose use cases in the pharmaceutical industry. Some of the largest pharma companies in the world are now conducting pilots and are expected to move towards production cases in the coming year. But for blockchain to succeed, several remaining obstacles must still be overcome.

  • 7 Speed Bumps To Avoid When Outsourcing Clinical Supply Manufacturing
    7 Speed Bumps To Avoid When Outsourcing Clinical Supply Manufacturing

    Any company with successful Phase 1 study data must ensure sufficient and consistent supply of drug product for possible Phase 2 and Phase 3 trials. For this reason, Phase 1 companies planning to outsource manufacturing of their clinical supply should take some essential steps early in the clinical manufacturing campaign to assure a timely and reliable supply of material throughout their clinical trials.

  • Examining FDA’s New Patient Labeling Draft Guidance
    Examining FDA’s New Patient Labeling Draft Guidance

    In accordance with the increasing emphasis on human factors as it applies to medical products and their associated written materials, the FDA recently released the draft guidance document Instructions for Use – Patient Labeling for Human Prescription Drug and Biological Products and Drug-Device and Biologic-Device Combination Products – Content and Format. Instructions for use (IFU) are a critical element of the device user interface, and special considerations must be accounted for in their design.

  • Pharmaceutical Transport Validation — Where To Begin?
    Pharmaceutical Transport Validation — Where To Begin?

    This article provides a road map for transport validation, which is used to qualify packaging for the entire product supply chain. When transport validation is done incompletely, poorly, or not at all, it can result in off-label drugs that are potentially harmful to patients.

  • FDA Analysis Of The Top Drug GMP Inspection Citations In FY2018
    FDA Analysis Of The Top Drug GMP Inspection Citations In FY2018

    In this two-part article, FDA supervisory consumer safety officer Dell Moller, Office of Pharmaceutical Quality Operations (OPQO) Division 3 program director Art Czabaniuk, and OPQO Division 3 investigator Lindsey Schwierjohann present the agency’s top 10 drug GMP inspection citations for FY2018 and provide insight into the observations. This part unveils citations #10 through #6, and Part 2 will cover citations #5 through #1.

  • Developing And Manufacturing Cell & Gene Therapies: Do Biopharma Methods Apply?
    Developing And Manufacturing Cell & Gene Therapies: Do Biopharma Methods Apply?

    Are the methods used for developing the current generation of biopharmaceuticals, monoclonal antibodies, hormone replacements, etc., applicable to the next generation of Cellular and gene therapies?

  • Project Execution Models For Biopharmaceutical Facilities
    Project Execution Models For Biopharmaceutical Facilities

    Project execution and project management are probably two of the topics that are most written about but least understood by the biopharmaceutical industry. This article is not about the theory of management, but it is a primer on approaches to project execution, some of which may assist the reader in understanding their path of least risk.

More From Our Expert Columnists

PHARMA ONLINE WHITE PAPERS

  • The Definitive Guide To Particle Sizing

    This paper provides an introduction to particle sizing comparing six widely used techniques, explaining how they work and what this means in terms of strengths and limitations. 

  • Under Pressure: Breaking The Misconceptions Of Maximum Compression Force

    It is common for tablet manufacturers to exceed the maximum compression force ratings of their tooling to form a quality tablet. However, going beyond the prescribed tooling rating may result in premature tool wear or failure and possible damage to the press. With proper formulation development and tablet design, the tablet press operator should be able to manufacture quality tablets without exceeding the tooling’s maximum compression force rating.

  • Advances In Single-Use Technologies For Cell Clarification

    One of the major challenges in batch mammalian cell clarification is cost-effective improvement in filtration in the face of high cell densities. 

  • What Clinical Teams Should Know About Changing Trial Logistics

    When it comes to clinical supplies, the journey is every bit as important as the destination and the price of failure is high. This paper discusses how supply logistics are changing and contains examples of how Fisher Clinical Services is deploying flexible solutions to ensure secure, efficient and cost-effective passage of clinical supplies.

  • The Future Of Shipping In Modern Medicine: Reusable Vs. Single-Use Shippers

    A shipping solution that maintains the temperature of a product in its  journey to the patient, preserves the intent of the medication, the safety of the investment, and the lives of the patients who depend on them.

More Pharma Onine White Papers

PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

PO_QualityManagementEbook_300x200

 

Free collection of articles exploring topics including the various types of risks associated with medicinal products, the role of risk management in pharmaceutical and biopharmaceutical regulation, QRM principles and practices, the role of QRM across the product life cycle, primary literature sources for QRM, and common challenges associated with QRM implementation.

More Content Collections

PHARMA INDUSTRY EVENTS

Amit gupta September 20 - 25, 2019
Chennai, AB
Infection Prevention 2019 September 22 - 24, 2019
Liverpool
10th International Conference On Herbals, Alternative & Traditional Medicine September 23 - 24, 2019
Deira, Near to Hamarain Shopping Center Dubai, UAE
International Conference on Pharmaceutics and Dru September 23 - 24, 2019
Barcelona
More Industry Events

TRAINING COURSES

Root Cause Analysis & CAPA Identification: A Step-by-Step Guide for Manufacturers September 24 - 24, 2019
1pm-2:30pm EDT, Online Training
Stability Programs – Key Factors in Meeting FDA/ICH Expectations September 26 - 26, 2019
1pm-2:30pm EDT, Online Training
Sterility Failure Investigations – A Step-by-Step Process for Success September 30 - 30, 2019
1pm-2:30pm EDT, Online Training
Clinical Research Project Management - 7 Breakthrough Behaviors For Success October 3 - 3, 2019
1pm-2:30pm EDT, Online Training
More Upcoming Courses